Home

NYSE:BRSP Stock Quote

5.5500
-0.0100 (-0.18%)

Brightspire Capital Inc is a real estate investment trust (REIT) focused on acquiring, managing, and financing commercial real estate properties across the United States

The company seeks to generate attractive risk-adjusted returns for its shareholders through a diversified portfolio that includes a range of property types such as office buildings, industrial sites, and multifamily residences. Brightspire Capital leverages its expertise in real estate investment and management to identify opportunities in the market, aiming to enhance asset value while providing steady income streams. The firm employs a disciplined investment strategy and actively engages in asset management to navigate market dynamics effectively.

SummaryNewsPress ReleasesChartHistoricalFAQ
Earnings Scheduled For February 18, 2025benzinga.com
Via Benzinga · February 18, 2025
Earnings Scheduled For February 21, 2024benzinga.com
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.
Via Benzinga · February 21, 2024
Earnings Preview For BrightSpire Capitalbenzinga.com
Via Benzinga · February 20, 2024
BRSP Stock Earnings: BrightSpire Capital Meets EPS, Beats Revenue for Q2 2024investorplace.com
BRSP stock results show that BrightSpire Capital met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · July 30, 2024
BRSP Stock Earnings: BrightSpire Capital Beats EPS, Beats Revenue for Q1 2024investorplace.com
BRSP stock results show that BrightSpire Capital beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 1, 2024
GameStop Posts Downbeat Results, Joins Direct Digital, Forge Global And Other Big Stocks Moving Lower In Wednesday's Pre-Market Sessionbenzinga.com
U.S. stock futures were higher this morning, with the Dow futures gaining by more than 100 points on Wednesday.
Via Benzinga · March 27, 2024
Downgrades Flood In For Commercial Real Estate Stocks: Analysts Warn Of 'Rocky Road Ahead'benzinga.com
Bank of America has downgraded six Commercial Real Estate mortgage REITs. Here's why.
Via Benzinga · March 4, 2024
US Mortgage Applications Surge As Rates Dip: Is The Industry Moving Out Of The Woods? Plus: Stocks, ETFs To Watchbenzinga.com
The latest data from the Mortgage Bankers Association (MBA) revealed a significant uptick in U.S. mortgage applications.
Via Benzinga · November 22, 2023
Earnings Outlook For BrightSpire Capitalbenzinga.com
Via Benzinga · October 27, 2023
Looking Into BrightSpire Capital's Return On Capital Employedbenzinga.com
Via Benzinga · May 9, 2023
BrightSpire Capital: Q1 Earnings Insightsbenzinga.com
Via Benzinga · May 3, 2023
These 3 REITs Just Jumped Higher On Earnings Beatsbenzinga.com
Via Benzinga · November 2, 2023
The Best-Performing Mortgage REITs In 2023benzinga.com
Among real estate investment trusts (REITs), one of the most popular subsectors with investors are mortgage REITs (mREITs). Although mREITs can be extremely volatile, their dividend yields are usually the highest among the total REIT universe.
Via Benzinga · March 3, 2023
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionbenzinga.com
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
Via Benzinga · March 1, 2023
Looking Into BrightSpire Capital's Return On Capital Employedbenzinga.com
Via Benzinga · February 22, 2023
Earnings Scheduled For October 30, 2023benzinga.com
Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter.
Via Benzinga · October 30, 2023
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023benzinga.com
Via Benzinga · March 1, 2023
Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarketbenzinga.com
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
Via Benzinga · March 1, 2023
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesdayinvestorplace.com
It's time to start the day with another breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!
Via InvestorPlace · March 1, 2023
Novavax, AMC Entertainment And Other Big Stocks Moving Lower In Wednesday's Pre-Market Sessionbenzinga.com
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via Benzinga · March 1, 2023
A Look Into Real Estate Sector Value Stocksbenzinga.com
Via Benzinga · January 16, 2023
These 3 Mortgage REITs Have Yields Of Over 13% And Are Trading For Far Less Than They're Worthbenzinga.com
The VanEck Mortgage REIT Income ETF (ARCA: MORT) is down roughly 31% year-to-date, as a series of interest rate hikes by the Federal Reserve has sent a shock through real estate-related industries. Mortgage REITs allow investors to join the real estate market without owning the physical property.
Via Benzinga · November 19, 2022
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022benzinga.com
Via Benzinga · December 6, 2022
BrightSpire Capital: Q3 Earnings Insightsbenzinga.com
BrightSpire Capital (NYSE:BRSP) reported its Q3 earnings results on Wednesday, November 2, 2022 at 08:30 AM. Here's what investors need to know about the announcement. Earnings BrightSpire Capital reported in-line EPS of $0.25 versus an estimate of $0.25.
Via Benzinga · November 2, 2022
BrightSpire Capital: Q2 Earnings Insightsbenzinga.com
  BrightSpire Capital (NYSE:BRSP) reported its Q2 earnings results on Wednesday, August 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via Benzinga · August 3, 2022